Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
Clinical trial NCT01684878 · COMPLETED
Trial details
- NCT number
- NCT01684878
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-22
- Primary completion
- 2015-01-30
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.